Daniel Roeser > Goodwin > New York, United States > Lawyer Profile
Goodwin Offices

THE NEW YORK TIMES BUILDING
620 EIGHTH AVENUE
NEW YORK NY 10018
NEW YORK
United States
- Firm Profile
- Go to...
Daniel Roeser

Position
Partner
Career
Dan Roeser is a partner in Goodwin’s Securities Litigation & White Collar Defense group and its Digital Currency & Blockchain Technology practice. Mr. Roeser represents companies and institutions, underwriters, and individuals in securities actions, shareholder derivative actions, and criminal and regulatory proceedings. His clients span a wide range of industries, including financial services, life sciences, and technology:
- Companies and Institutions: Mr. Roeser has represented an array of domestic and international companies and institutions, including Cognizant Technology Solutions Corporation; Countrywide Financial Corporation, the Tezos Foundation, and Nomura Securities International, Inc.
- Underwriters: Mr. Roeser has represented syndicates of investment banks that underwrote primary and secondary public offerings of issuers across several industries, including financial services, money transfer and payment services, and life sciences.
- Individuals: Mr. Roeser has represented a series of C-suite officers and other individuals, including the former CEO of Wells Fargo; the former CEO of Petrobras; the Chairman and CEO of Caesars Entertainment Corporation; and the CFO of Pfizer, Inc.
- Criminal and Regulatory Proceedings: Mr. Roeser has represented individuals and institutions in criminal insider trading cases and investigations by the United States Attorney’s Office, the Securities and Exchange Commission, and the Chicago Mercantile Exchange.
Mr. Roeser’s cases involve some of the most high-profile matters of their kind, such as the Wells Fargo, Petrobras and Caesars litigations, as well as legal issues that are at the leading edge of securities law, such as digital currency + blockchain technology; high frequency, algorithmic trading; and spoofing.
Education
JD, Harvard Law School (cum laude) 2002 / AB, Harvard College (magna cum laude) 1997
Lawyer Rankings
United States > Dispute resolution > Securities litigation: defense
(Leading partners)Drawing upon deep industry knowledge in core firmwide areas of sector strength, Goodwin is very effective at representing life sciences, tech, real estate and financial services clients in securities litigation and derivative actions in state and federal cases throughout the country. Boston-based Deborah Birnbach has significant expertise handling both private litigation and regulatory investigations, regularly advising companies, as well as their directors and officers, in securities and shareholder litigation and corporate governance matters. In New York, Daniel Roeser has vast experience for an eclectic client base that includes public companies, executives and banks, in the defense of often cutting-edge securities litigation matters, including as it relates to SPACs, cryptocurrency and high frequency trading. Other key members of the team include New York based Douglas Flaum, who regularly handles complex securities litigation in the real estate sector, including for REITs; San Francisco-based Jonathan Shapiro, who is skilled at guiding tech-focused companies (including fintech entities) respond to securities class actions and government investigations and is a key member of the firm’s growing litigation presence in California; and in Boston, Caroline Bullerjahn, who is adept at defending biotech/life sciences companies in securities fraud litigation in courts throughout the country.
Lawyer Rankings
- Leading partners United States > Dispute resolution > Securities litigation: defense
- Securities litigation: defense United States > Dispute resolution
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation